Evidence map›Paper›PMID 30674080›Full record

ArticleJournal of the American Geriatrics Society2019

Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.

Christina A Spivey, Yanru Qiao, Junling Wang, Ya-Chen Tina Shih, Jim Y Wan, Samuel Dagogo-Jack, William C Cushman, Lisa E Hines, Marie A Chisholm-Burns

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Racial and ethnic disparities in the enrolment of medicare medication therapy management programs.Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christina A SpiveyDepartment of Clinical Pharmacy and Translational Science, University of Tennessee College of Pharmacy, Memphis, Tennessee.
Yanru QiaoHealth Outcomes and Policy Research, Department of Clinical Pharmacy and Translational Science, University of Tennessee College of Pharmacy, Memphis, Tennessee.
Junling WangHealth Outcomes and Policy Research, Department of Clinical Pharmacy and Translational Science, University of Tennessee College of Pharmacy, Memphis, Tennessee.
Ya-Chen Tina ShihDepartment of Health Services Research & Chief, Section of Cancer Economics and Policy, The University of Texas MD Anderson Cancer, Houston, Texas.
Jim Y WanDepartment of Preventive Medicine, University of Tennessee College of Medicine, Memphis, Tennessee.
Samuel Dagogo-JackDivision of Endocrinology, Diabetes & Metabolism & Clinical Research Center, University of Tennessee College of Medicine, Memphis, Tennessee.
William C CushmanDepartment of Preventive Medicine and Medicine, University of Tennessee College of Medicine & Chief, Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, Tennessee.
Lisa E HinesMeasure Operations & Analytics, Pharmacy Quality Alliance, Alexandria, Virginia.
Marie A Chisholm-BurnsUniversity of Tennessee College of Pharmacy, Memphis, Knoxville and Nashville, Tennessee.

Funding

Resolving Racial/Ethnic Disparities Associated with Star Ratings among the ADRD PopulationR01AG049696 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WANG, JUNLING NONE · 2015 to 2022
$2.9M
NIA NIH HHS R01 AG049696
6 · The paper itself

Abstract

BACKGROUND/

objectivesPrevious research indicates that eligibility criteria for medication therapy management (MTM) services in Medicare prescription drug (Part D) plans, defined under the Medicare Modernization Act (MMA), are associated with racial/ethnic disparities and ineffective in identifying individuals with medication utilization issues. Our study's objective was to determine the comparative effectiveness of MTM eligibility criteria under MMA and in the Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial/ethnic groups.

designACA and MMA MTM eligibility criteria were compared on proportions of eligible individuals among patients with medication utilization issues. Multinomial logistic regression was conducted to control for patient/community characteristics. Need-based and demand-based analyses were used to determine disparities due to need and demand for healthcare. Main/sensitivity analyses were conducted for the range of eligibility thresholds.

settingMedicare data (2012-2013) linked to Area Health Resources Files.

participantsA total of 964 610 patients 65 years or older. MEASUREMENTS: Medication safety/adherence measures, developed primarily by the Pharmacy Quality Alliance, were used to determine medication utilization issues.

resultsHigher proportions of patients were eligible based on ACA than MMA MTM eligibility criteria. For example, in 2013, proportions based on ACA and MMA MTM eligibility criteria would be 99.7% and 26.2%, respectively, in the main analysis (p < .001); in the demand-based main analysis, ACA criteria were associated with 13.6% and 9.8%, respectively, higher effectiveness than MMA criteria among non-Hispanic blacks and Hispanics than non-Hispanic whites.

conclusionACA MTM eligibility criteria are more effective than MMA criteria in identifying older patients needing MTM, particularly among minorities. J Am Geriatr Soc 67:581-587, 2019.

Indexed as

Eligibility DeterminationHealthcare DisparitiesMedication Therapy ManagementAgedDrug Utilization ReviewEthnicityFemaleHumansMaleMedicare Part DMinority HealthPatient SelectionPharmaceutical ServicesPractice Patterns, Physicians'Retrospective StudiesUnited StatesAffordable Care ActMedicare Modernization Actmedication therapy management

Identifiers

PMID30674080
PMCPMC6438366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.